KYN | SRV | KYN / SRV | |
Gain YTD | -3.189 | 5.130 | -62% |
Net Assets | 2.23B | 186M | 1,201% |
Total Expense Ratio | 5.18 | 2.84 | 182% |
Turnover | 51.70 | 141.29 | 37% |
Yield | 2.01 | 0.00 | - |
Fund Existence | 21 years | 18 years | - |
KYN | SRV | |
---|---|---|
RSI ODDS (%) | 4 days ago90% | 4 days ago90% |
Stochastic ODDS (%) | 4 days ago90% | 4 days ago90% |
Momentum ODDS (%) | 4 days ago76% | 4 days ago81% |
MACD ODDS (%) | 4 days ago79% | 4 days ago76% |
TrendWeek ODDS (%) | 4 days ago78% | 4 days ago74% |
TrendMonth ODDS (%) | 4 days ago77% | 4 days ago79% |
Advances ODDS (%) | 6 days ago90% | 7 days ago90% |
Declines ODDS (%) | 4 days ago78% | 5 days ago75% |
BollingerBands ODDS (%) | 4 days ago87% | 4 days ago90% |
Aroon ODDS (%) | N/A | 4 days ago90% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFAX | 14.53 | 0.10 | +0.69% |
AlphaCentric Life Sciences & Hlthcare A | |||
PLGJX | 10.92 | 0.06 | +0.55% |
Principal LargeCap Growth I J | |||
NQVCX | 55.74 | 0.27 | +0.49% |
Nuveen Multi Cap Value C | |||
IBARX | 26.04 | 0.07 | +0.27% |
Macquarie Balanced Fund Class R6 | |||
EMEAX | 14.19 | -0.06 | -0.42% |
Ashmore Emerging Markets Equity A |
A.I.dvisor tells us that KYN and EPD have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KYN and EPD's prices will move in lockstep.
A.I.dvisor tells us that SRV and HESM have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SRV and HESM's prices will move in lockstep.
Ticker / NAME | Correlation To SRV | 1D Price Change % | ||
---|---|---|---|---|
SRV | 100% | +0.43% | ||
HESM - SRV | 20% Poorly correlated | -0.27% | ||
KMI - SRV | 14% Poorly correlated | +0.62% | ||
OKE - SRV | 13% Poorly correlated | +1.29% | ||
PAGP - SRV | 10% Poorly correlated | -0.30% | ||
WES - SRV | 9% Poorly correlated | +0.29% | ||
More |